TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 4 | -1 | -4 | -4 | 12 | 15 | 49 | 11 |
| S | %wins | 75 | 75 | 75 | 25 | 25 | 0 | 46 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/17/16 07:47 | 8/15/16 | CBPO | China Biologic Products, Inc. | Health | BioPrd | Biological Products, (No Diag | Yang Ming | F4 | O | CFO | S | -2,622 | 124.32 | 27 | -21 | -46 | 25 | D | 174 | 12 | 5 | 10 | 11 | 6 | -7 | -2 | -3 | -8 | -2 | -1 | -9 | ||
5/23/16 16:35 | 5/19/16 | CBPO | China Biologic Products, Inc. | Health | BioPrd | Biological Products, (No Diag | Yang Ming | F4 | O | CFO | S.dm | -1,581 | 113.64 | 30 | -14 | -27 | 38 | D | 185 | 5 | -3 | -2 | -5 | -6 | -4 | 0 | 0 | 2 | -7 | 1 | 1 | ||
9/16/15 16:16 | 9/14/15 | CBPO | China Biologic Products, Inc. | Health | BioPrd | Biological Products, (No Diag | Yang Ming | F4 | O | CFO | S.dm | -1,948 | 95.96 | 28 | -20 | -45 | 25 | D | 288 | 73 | 13 | -18 | -24 | 0 | 0 | -5 | 2 | -5 | 6 | 30 | 17 | 27 | |
9/16/14 16:50 | 9/12/14 | CBPO | China Biologic Products, Inc. | Health | BioPrd | Biological Products, (No Diag | Yang Ming | F4 | O | CFO | S.m | -333 | 54.00 | 3 | -6 | -31 | 14 | D | 513 | 124 | 51 | 14 | 21 | 5 | 2 | 2 | -3 | -3 | -12 | 17 | 51 | 71 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |